ACE2 and COVID-19: The current understanding of the pathomechanism of COVID-19 suggests that angiotensin enzyme 2 (ACE2) is the host functional receptor for SARS-CoV-2, which hyperactivates an immune response predominated by T-helper (Th)-1 cells which results in lung impairment [30].